Factors Influencing Clinical Trials of Herbal Medicinal Products – Using Ginger as Example
Planta Medica · 01.12.2025 · 91 (15) · 880-890
DOI: 10.1055/a-2686-6315 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Planta Medica, erschienen am 01.12.2025. Verfasst von Ingrid Hook und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, University of Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Zingiber officinale, Clinical Trials as Topic, Phytotherapy, Plant Preparations. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 142 Literaturangaben.
Abstract (Originalsprache)
Ginger (Zingiber officinale) has a global use as a spice, an ingredient of beverages, food supplements (syn. dietary supplements), as well as herbal medicinal products. Since the last update of ginger in ESCOP Monographs in 2009 a significant number of papers concerning its bioactive constituents and clinical uses have been published. From this large number and selecting those references (almost 500) considered most relevant to clinical aspects and therapeutic indications, the following issues are considered to be potentially important to research on other medicinal plants: [i] quality assessment; [ii] pre-clinical (in vivo) studies; [iii] quality of clinical trials; [iv] ethnicity of clinical trial participants and [v] effects of sex-gender on activity and therapeutic indications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, University of Dublin, Dublin, Ireland.
- ESCOP, Notaries House, Exeter, UK.
- Division of Pharmacognosy, University Vienna, Austria.
- Natural Products and Phytopharmacy Research Group, Institute of Chemistry & Biotechnology, Zürich University of Applied Sciences, Wädenswil, Switzerland.
ORCID-Profile: Liselotte Krenn
Zitieren
APA
Hook, I., Krenn, L., Steinhoff, B., & Wolfram, E. (2025). Factors Influencing Clinical Trials of Herbal Medicinal Products – Using Ginger as Example. Planta Medica, 91(15), 880-890. https://doi.org/10.1055/a-2686-6315
Vancouver
Hook I, Krenn L, Steinhoff B, Wolfram E. Factors Influencing Clinical Trials of Herbal Medicinal Products – Using Ginger as Example. Planta Medica. 2025;91(15):880-890. doi:10.1055/a-2686-6315
BibTeX
@article{Hook2025,
author = {Hook, Ingrid and Krenn, Liselotte and Steinhoff, Barbara and Wolfram, Evelyn},
title = {Factors Influencing Clinical Trials of Herbal Medicinal Products – Using Ginger as Example},
journal = {Planta Medica},
year = {2025},
volume = {91},
number = {15},
pages = {880--890},
doi = {10.1055/a-2686-6315}
}
EUVIMED